These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17145534)

  • 1. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
    Mornex F; Girard N; Beziat C; Kubas A; Khodri M; Trepo C; Merle P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1152-8. PubMed ID: 17145534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
    Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
    Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
    Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
    Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
    Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma.
    Liang SX; Zhu XD; Lu HJ; Pan CY; Li FX; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
    Cancer; 2005 May; 103(10):2181-8. PubMed ID: 15812834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
    Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.
    Kawashima M; Furuse J; Nishio T; Konishi M; Ishii H; Kinoshita T; Nagase M; Nihei K; Ogino T
    J Clin Oncol; 2005 Mar; 23(9):1839-46. PubMed ID: 15774777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy.
    Merle P; Mornex F; Trepo C
    Cancer Lett; 2009 Dec; 286(1):129-33. PubMed ID: 19138819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful preoperative treatment for hepatocellular carcinoma with tumor thrombus in the major portal branch by three-dimensional conformal radiation therapy--two case reports.
    Wada H; Sasaki Y; Yamada T; Ohigashi H; Miyashiro I; Murata K; Doki Y; Ishikawa O; Nishiyama K; Imaoka S
    Hepatogastroenterology; 2005; 52(62):343-7. PubMed ID: 15816431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
    Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
    Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
    Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
    Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
    Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
    Hamamoto Y; Niino K; Ishiyama H; Hosoya T
    Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.
    Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Br J Radiol; 2007 Mar; 80(951):194-201. PubMed ID: 17038412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.
    Lambert B; Bacher K; De Keukeleire K; Smeets P; Colle I; Jeong JM; Thierens H; Troisi R; De Vos F; Van de Wiele C
    J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.